Skip to main content

S. 73

Referred to Committee

End Taxpayer Subsidies for Drug Ads Act

Introduced 1/10/2019•116th Congress•Senate

Latest Action

Read twice and referred to the Committee on Finance.

1/10/2019 • Senate

Summary

End Taxpayer Subsidies for Drug Ads Act

This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs.

"Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.

Introduced in Senate • 1/10/2019

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Taxation
Business expensesIncome tax deductionsMarketing and advertisingPrescription drugs

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (23)

Party Breakdown

21
Democrats
0
Republicans
2
Independents

Sponsor

S[
Sen. Shaheen, Jeanne [D-NH]

Democrat • NH

Sponsored 1/10/2019

Cosponsors (22)

S[
Sen. Brown, Sherrod [D-OH]

D-OH

Joined 1/10/2019

S[
S[
S[
S[
Sen. Baldwin, Tammy [D-WI]

D-WI

Joined 1/10/2019

Bill Journey

Originated in the Senate

Introduced

January 10, 2019

Read twice and referred to the Committee on Finance.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in Senate1/10/2019

Details

Bill TypeS
Current StatusReferred to Committee
Cosponsors22